The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules

Journal of Hepatology

Volumn 49, Issue 1, 2008, Pages 61-71

  Rebouissou, Sandra ^a,b   Couchy, Gabrielle ^a,b   Libbrecht, Louis ^c   Balabaud, Charles ^d,e   Imbeaud, Sandrine ^f,g   Auffray, Charles ^f   Roskams, Tania ^c   Bioulac Sage, Paulette ^d,h   Zucman Rossi, Jessica ^a,b  

^a Université Paris 13   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d INSERM   (France)

^e HÔPITAL SAINT ANDRÉ   (France)

^f Functional Genomics and Systems Biology for Health   (France)

^g CNRS   (France)

^h HÔPITAL PELLEGRIN   (France)

Author keywords

Catenin; Benign tumor; Diagnostic markers; Focal nodular hyperplasia; Glutamine synthetase; Microarray; Transcriptome; Zonation

Indexed keywords

BETA CATENIN; GLUTAMATE AMMONIA LIGASE; TRANSCRIPTOME;

ADULT; AGED; ANASTOMOSIS; ARTICLE; CONTROLLED STUDY; DEREGULATION; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VEIN ANASTOMOSIS;

ADULT; AGED; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; FOCAL NODULAR HYPERPLASIA; GENE EXPRESSION PROFILING; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 44649146372     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.03.013     Document Type: Article

References (44)

1. Edmondson H.A. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology (1958), Armed Forces Institute of Pathology, Washington, DC
2. Rebouissou S., Bioulac-Sage P., and Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48 (2008) 163-170
3. Wanless I.R., Mawdsley C., and Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5 (1985) 1194-1200
4. Vilgrain V., Flejou J.F., Arrive L., Belghiti J., Najmark D., Menu Y., et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184 (1992) 699-703
5. Bioulac-Sage P., Balabaud C., and Wanless I.R. Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 25 (2001) 1322-1325
6. Cherqui D., Rahmouni A., Charlotte F., Boulahdour H., Metreau J.M., Meignan M., et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22 (1995) 1674-1681
7. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983-93.
8. Bioulac-Sage P., Balabaud C., Bedossa P., Scoazec J.Y., Chiche L., Dhillon A.P., et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46 (2007) 521-527
9. Fukukura Y., Nakashima O., Kusaba A., Kage M., and Kojiro M. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol 29 (1998) 470-475
10. Wanless I.R., Albrecht S., Bilbao J., Frei J.V., Heathcote E.J., Roberts E.A., et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 2 (1989) 456-462
11. Gaffey M.J., Iezzoni J.C., and Weiss L.M. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148 (1996) 1089-1096
12. Chen T.C., Chou T.B., Ng K.F., Hsieh L.L., and Chou Y.H. Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis. Virchows Arch 438 (2001) 408-411
13. Zhang S.H., Cong W.M., and Wu M.C. Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis. J Clin Pathol 57 (2004) 556-559
14. Paradis V., Laurent A., Flejou J.F., Vidaud M., and Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 26 (1997) 891-895
15. Bioulac-Sage P., Rebouissou S., Sa Cunha A., Jeannot E., Lepreux S., Blanc J.F., et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128 (2005) 1211-1218
16. Chen Y.J., Chen P.J., Lee M.C., Yeh S.H., Hsu M.T., and Lin C.H. Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes Chromosomes Cancer 35 (2002) 138-143
17. Chen Y.W., Jeng Y.M., Yeh S.H., and Chen P.J. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 36 (2002) 927-935
18. Blaker H., Sutter C., Kadmon M., Otto H.F., Von Knebel-Doeberitz M., Gebert J., et al. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. Genes Chromosomes Cancer 41 (2004) 93-98
19. Libbrecht L., Cassiman D., Verslype C., Maleux G., Van Hees D., Pirenne J., et al. Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101 (2006) 2341-2346
20. Quaglia A., Tibballs J., Grasso A., Prasad N., Nozza P., Davies S.E., et al. Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42 (2003) 14-21
21. Nakashima O., Kurogi M., Yamaguchi R., Miyaaki H., Fujimoto M., Yano H., et al. Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules?. J Hepatol 41 (2004) 992-998
22. Bioulac-Sage P., Rebouissou S., Thomas C., Blanc J.F., Sa Cunha A., Rullier A., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46 (2007) 740-748
23. Zucman-Rossi J., Jeannot E., Nhieu J.T., Scoazec J.Y., Guettier C., Rebouissou S., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43 (2006) 515-524
24. Graudens E., Boulanger V., Mollard C., Mariage-Samson R., Barlet X., Gremy G., et al. Deciphering cellular states of innate tumor drug responses. Genome Biol 7 (2006) R19
25. Rebouissou S., Vasiliu V., Thomas C., Bellanne-Chantelot C., Bui H., Chretien Y., et al. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet 14 (2005) 603-614
26. Benhamouche S., Decaens T., Godard C., Chambrey R., Rickman D.S., Moinard C., et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 10 (2006) 759-770
27. Braeuning A., Ittrich C., Kohle C., Buchmann A., and Schwarz M. Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas. Drug Metab Dispos 35 (2007) 503-507
28. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21 (2002) 8293-8301
29. Paradis V., Bieche I., Dargere D., Laurendeau I., Nectoux J., Degott C., et al. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 124 (2003) 651-659
30. de La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95 (1998) 8847-8851
31. Miyoshi Y., Iwao K., Nagasawa Y., Aihara T., Sasaki Y., Imaoka S., et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58 (1998) 2524-2527
32. Monga S.P., Monga H.K., Tan X., Mule K., Pediaditakis P., and Michalopoulos G.K. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124 (2003) 202-216
33. Monga S.P., Pediaditakis P., Mule K., Stolz D.B., and Michalopoulos G.K. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33 (2001) 1098-1109
34. Tan X., Behari J., Cieply B., Michalopoulos G.K., and Monga S.P. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 131 (2006) 1561-1572
35. Moorman A.F., de Boer P.A., Geerts W.J., van den Zande L., Lamers W.H., and Charles R. Complementary distribution of carbamoylphosphate synthetase (ammonia) and glutamine synthetase in rat liver acinus is regulated at a pretranslational level. J Histochem Cytochem 36 (1988) 751-755
36. Lepreux S., Desmouliere A., Rosenbaum J., Balabaud C., and Bioulac-Sage P. Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability. Comp Hepatol 3 (2004) S57
37. Scoazec J.Y., Flejou J.F., D'Errico A., Couvelard A., Kozyraki R., Fiorentino M., et al. Focal nodular hyperplasia of the liver: composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules. Hum Pathol 26 (1995) 1114-1125
38. Theuerkauf I., Zhou H., and Fischer H.P. Immunohistochemical patterns of human liver sinusoids under different conditions of pathologic perfusion. Virchows Arch 438 (2001) 498-504
39. Butron Vila M.M., Haot J., and Desmet V.J. Cholestatic features in focal nodular hyperplasia of the liver. Liver 4 (1984) 387-395
40. Lotz G., Nagy P., Patonai A., Kiss A., Nemes B., Szalay F., et al. TGF-beta and apoptosis in human hepatocellular carcinoma and focal nodular hyperplasia. J Hepatol 28 (1998) 175
41. Nusse R. Wnt signaling in disease and in development. Cell Res 15 (2005) 28-32
42. Labbe E., Lock L., Letamendia A., Gorska A.E., Gryfe R., Gallinger S., et al. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 67 (2007) 75-84
43. Zhang M., Lee C.H., Luo D.D., Krupa A., Fraser D., and Phillips A.O. Polarity of response to TGF-beta 1 in proximal tubular epithelial cells (PTC) is regulated by beta-catenin. J Biol Chem 282 (2007) 28639-28647
44. Ueberham E., Arendt E., Starke M., Bittner R., and Gebhardt R. Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice. J Hepatol 41 (2004) 75-81